Zura Bio (ZURA) Research & Development (2022 - 2026)
Zura Bio's Research & Development was $20.71 million in Q2 2026, up 137.9% from $8.7 million a year earlier and up 40.4% from the prior quarter.
Powered by 
Analysis
Zura Bio (ZURA) Research & Development (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Zura Bio's Research & Development was $58.36 million through Jun 30, 2026, up 69.4% year-over-year; for FY2025, it was $42.08 million, up 72.5% from FY2024.
- Research & Development shows a three-year compound annual growth rate of 21.1% (FY2022 to FY2025).
- In earlier years, Research & Development was $24.4 million in FY2024 (-44.5%), $44 million in FY2023 (+85.7%) and $23.69 million in FY2022.
- The Q2 2026 figure marks the highest quarterly Research & Development since Q2 2023.
- Compared with a year earlier, Research & Development has increased for eight straight quarters, with growth averaging 78.7% over the last eight quarters.
- The best year-over-year quarter for Research & Development over five years was Q3 2023 (growth of 855.4%); the worst was Q2 2024 (a decline of 80.4%).
- Per Business Quant data, ZURA's Research & Development in the three quarters before Q2 2026 was $14.75 million (Q1 2026), $10.96 million (Q4 2025) and $11.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Zura Bio | 527.50 Mn | 527.50 Mn | - | 20.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.71 Mn |
| Mar 31, 2026 | 14.75 Mn |
| Dec 31, 2025 | 10.96 Mn |
| Sep 30, 2025 | 11.95 Mn |
| Jun 30, 2025 | 8.70 Mn |
| Mar 31, 2025 | 10.47 Mn |
| Dec 31, 2024 | 9.24 Mn |
| Sep 30, 2024 | 6.03 Mn |
| Jun 30, 2024 | 5.54 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 6.92 Mn |
| Sep 30, 2023 | 3.97 Mn |
| Jun 30, 2023 | 28.23 Mn |
| Mar 31, 2023 | 4.88 Mn |
| Dec 31, 2022 | 15.69 Mn |
| Sep 30, 2022 | 415,000.00 |
| Jun 30, 2022 | 85,000.00 |
| Mar 31, 2022 | 7.50 Mn |
API Access
Zura Bio Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ZURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ZURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ZURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();